首页 | 本学科首页   官方微博 | 高级检索  
检索        

银杏叶提取物在治疗慢性肺心病中的抗血小板作用
引用本文:邢国宏,孙晓明,周士发,李跃珍,王立欣,刘军.银杏叶提取物在治疗慢性肺心病中的抗血小板作用[J].中国临床药学杂志,2000,9(4):209-211.
作者姓名:邢国宏  孙晓明  周士发  李跃珍  王立欣  刘军
作者单位:中国人民解放军济南军区 总医院保健三科 济南 250031
摘    要:目的:观察银杏叶提取物(Egb761)在肺心病治疗中的作用,特别是抗血小板作用。方法:用流式细胞方法测定了2组慢性肺心病患者治疗前后的血小板表面CD41和CD62p表达变化。结果:2组病人治疗后CD41和CD62p表达均显著降低,Egb761治疗组较一般治疗更明显。结论:Egb761具有良好的改善血小板功能的作用,是一种有效的肺心病治疗辅助药。

关 键 词:慢性肺心病  抗血小板治疗  银杏叶提取物
文章编号:1007-4406(2000)04-0209-03

Effect of Ginkgo biloba extracts on platelet function in patients w ith chronic pulmonary heart disease
Xing Guohong,Sun Xiaoming,Zhou Shifa,et al.Effect of Ginkgo biloba extracts on platelet function in patients w ith chronic pulmonary heart disease[J].Chinese Journal of Clinical Pharmacy,2000,9(4):209-211.
Authors:Xing Guohong  Sun Xiaoming  Zhou Shifa  
Abstract:AIM: To investigate the effect of Ginkgo biloba extracts (Egb761) on platelet function in patients with chronic pulmonary heart disease. METHODS: The expression of CD 41 and CD 62p on platelet membrane was detected by flow cytometry method in Egb761 and control group patients before and after treatment, respectively. RESULTS: The percentages of CD 41 and CD 62p expression were significantly decreased in both group patients after treatment compared with before. And CD 41 and CD 62p in trial group were lower than those in control group. CONCLUSION: Egb761 can be used to inhibit the activation of platelet. Antiplatelet therapy is applicable for chronic pulmonary heart disease.
Keywords:chronic pulmonary heart disease  antiplatelet treatment  Ginkgo biloba  extracts (Egb761)
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号